February 16, 2018 / 1:11 AM / 8 months ago

BRIEF-United Therapeutics Settles Patent Litigation With Actavis Laboratories FL

Feb 15 (Reuters) - United Therapeutics Corp:

* UNITED THERAPEUTICS ANNOUNCES SETTLEMENT OF PATENT LITIGATION WITH ACTAVIS LABORATORIES FL, INC. RELATING TO ORENITRAM

* ‍ENTERED INTO A SETTLEMENT AGREEMENT WITH ACTAVIS LABORATORIES FL, INC RESOLVING ONGOING LITIGATION​

* ‍UNDER SETTLEMENT AGREEMENT, CO GRANTED TO ACTAVIS LICENSE TO MANUFACTURE AND COMMERCIALIZE GENERIC VERSION OF ORENITRAM

* SAYS PARTIES WILL ALSO TERMINATE PENDING LITIGATION CONCERNING PATENTS RELATING TO ACTAVIS' ANDA.

* UNITED THERAPEUTICS - ‍LICENSE IN SETTLEMENT AGREEMENT DOES NOT PERMIT ACTAVIS TO MANUFACTURE GENERIC VERSION OF ANY OTHER UNITED THERAPEUTICS PRODUCT​

* ‍ AGREEMENT DOES NOT GRANT ACTAVIS ANY RIGHTS OTHER THAN THOSE REQUIRED TO LAUNCH ACTAVIS' GENERIC VERSION OF ORENITRAM​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below